Patents by Inventor Bernd Hentsch

Bernd Hentsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040254346
    Abstract: Survivin Interacting Protein 1 and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing SIP-1 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: September 24, 2002
    Publication date: December 16, 2004
    Inventors: Bernd Hentsch, Klaus Ducker, Bjorn Hock
  • Publication number: 20040072999
    Abstract: IAPL-7 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods are utilizing IAPL-7 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: September 17, 2003
    Publication date: April 15, 2004
    Inventor: Bernd Hentsch
  • Publication number: 20040039166
    Abstract: IAPL-3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IAPL-3 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: August 19, 2003
    Publication date: February 26, 2004
    Inventor: Bernd Hentsch
  • Publication number: 20040039185
    Abstract: IAPL-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IAPL-2 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: March 6, 2003
    Publication date: February 26, 2004
    Inventor: Bernd Hentsch
  • Publication number: 20040014706
    Abstract: The present invention relates to the novel finding that inhibition of human CARP protein or of CARP DNA/mRNA may successfully cure heart disorders, especially heart failure in humans. The invention relates, therefore, to pharmaceutical compositions containing substances, preferably of lower molecular weight, which may influence the activity of cardiac CARP. The invention relates, furthermore, to a method of treatment heart failure using CARP inhibitory compounds, to methods for screening these inhibitors and to the use of CARP as diagnostic tool.
    Type: Application
    Filed: August 7, 2003
    Publication date: January 22, 2004
    Inventors: Franz-Werner Kluxen, Bernd Hentsch, Claudia Wilm, Marian Braendle, Thomas Eschenhagen, Thomas Eschenhagen, Oliver Zolk